Markus Metzger
Keine laufenden Positionen mehr
Profil
Markus Metzger worked as a Senior Research Analyst at Vontobel Securities AG (Germany) and as a Vice President-Investor Relations at STADA Arzneimittel AG.
He holds a doctorate degree from Heinrich-Heine-Universität Düsseldorf.
Ehemalige bekannte Positionen von Markus Metzger
| Unternehmen | Position | Ende |
|---|---|---|
| STADA ARZNEIMITTEL | Investor Relations Kontakt | 08.09.2016 |
| Vontobel Securities AG (Germany) | Analyst-Equity | - |
Ausbildung von Markus Metzger
| Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
| Vontobel Securities AG (Germany) | Finance |